Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study

• المؤلفون الرئيسيون: Matti Kivikko, MD, PhD (مؤلف), Mikko Kuoppamäki, MD, PhD (مؤلف), Lauri Soinne, MD, PhD (مؤلف), Stig Sundberg, PhD (مؤلف), Pasi Pohjanjousi, MSc (مؤلف), Juha Ellmen, PhD (مؤلف), Risto O. Roine, MD, PhD (مؤلف)
• التنسيق: كتاب
• منشور في: Elsevier, 2015-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: Intravenous levosimendan is indicated for acute heart failure. The compound has shown promising beneficial effects in ischemic stroke models. Objective: We evaluated the efficacy and safety of oral levosimendan in patients with a history of cerebral ischemia. Methods: In a randomized, do...